The US Supreme Court has rejected both Nautilus’s and Covidien’s attempt to reverse patent infringement judgments in two separate disputes centring on medical devices.
A group of technology companies has urged the US Supreme Court to re-hear the Nautilus v Biosig case, arguing that the US Court of Appeals for the Federal Circuit failed to apply the “reasonable certainty” standard for determining whether a patent claim is indefinite.
Abbott Laboratories has successfully obtained an injunction against a number of US retailers selling ‘grey good’ strips for diabetics that had been manufactured in Ireland and later sold in the US at a lower price.
Electronic transmissions of data do not count as “articles” under the 1930 Tariff Act and the International Trade Commission overstepped its mark in halting their transmission, the US Court of Appeals for the Federal Circuit has ruled.
Wearable technology maker Jawbone has accused rival Fitbit of using patent litigation and “poaching” key employees to hurt it commercially in an anti-competition claim filed at a US court.
Wearable technology company Fitbit has accused competitor Aliphcom of infringing a number of its patents covering devices that record an individual’s fitness.
The US Court of Appeals for the Federal Circuit issued two separate judgments concerning the alleged infringement of a patent covering an access control mechanism for a wireless network by medical device makers Medtronic and St. Jude Medical.
There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.
Ariosa Diagnostics has urged the US Court of Appeals for the Federal Circuit to reject Sequenom’s en banc request, stating that behind its “sky is falling” rhetoric is really a demand for courts to revise the US Supreme Court’s two-part test in determining the eligibility of a patent.
The US Supreme Court has declined to hear manufacturer W L Gore & Associates’s request for clarity on whether US patent law stipulates that patent licensing agreements must be placed in writing.